- Home
- RYTM vs AGO Comparison
RYTM vs AGO Comparison
Compare RYTM & AGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- AGO
- Stock Information
- Founded
- RYTM 2008
- AGO 2003
- Country
- RYTM United States
- AGO Bermuda
- Employees
- RYTM N/A
- AGO 361
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- AGO Property-Casualty Insurers
- Sector
- RYTM Health Care
- AGO Finance
- Exchange
- RYTM Nasdaq
- AGO Nasdaq
- Market Cap
- RYTM 4.3B
- AGO 4.2B
- IPO Year
- RYTM 2017
- AGO 2004
- Fundamental
- Price
- RYTM $61.99
- AGO $86.30
- Analyst Decision
- RYTM Strong Buy
- AGO Buy
- Analyst Count
- RYTM 12
- AGO 3
- Target Price
- RYTM $76.75
- AGO $103.33
- AVG Volume (30 Days)
- RYTM 525.0K
- AGO 308.3K
- Earning Date
- RYTM 08-05-2025
- AGO 08-06-2025
- Dividend Yield
- RYTM N/A
- AGO 1.57%
- EPS Growth
- RYTM N/A
- AGO N/A
- EPS
- RYTM N/A
- AGO 8.34
- Revenue
- RYTM $136,863,000.00
- AGO $884,000,000.00
- Revenue This Year
- RYTM $37.56
- AGO N/A
- Revenue Next Year
- RYTM $74.99
- AGO N/A
- P/E Ratio
- RYTM N/A
- AGO $10.26
- Revenue Growth
- RYTM 48.88
- AGO N/A
- 52 Week Low
- RYTM $39.46
- AGO $72.57
- 52 Week High
- RYTM $69.89
- AGO $96.50
- Technical
- Relative Strength Index (RSI)
- RYTM 47.67
- AGO 55.65
- Support Level
- RYTM $60.70
- AGO $83.64
- Resistance Level
- RYTM $62.65
- AGO $86.62
- Average True Range (ATR)
- RYTM 2.39
- AGO 1.45
- MACD
- RYTM -0.52
- AGO 0.21
- Stochastic Oscillator
- RYTM 14.04
- AGO 81.85
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About AGO Assured Guaranty Ltd.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal, and healthcare experience. The company operates in two segments: the Insurance segment and the Asset Management segment. The majority of the revenue earned by the company is from the Insurance segment.